vs

Side-by-side financial comparison of Mayville Engineering Company, Inc. (MEC) and MEDIFAST INC (MED). Click either name above to swap in a different company.

Mayville Engineering Company, Inc. is the larger business by last-quarter revenue ($134.3M vs $75.1M, roughly 1.8× MEDIFAST INC). On growth, Mayville Engineering Company, Inc. posted the faster year-over-year revenue change (10.7% vs -36.9%). Mayville Engineering Company, Inc. produced more free cash flow last quarter ($10.2M vs $-6.6M). Over the past eight quarters, Mayville Engineering Company, Inc.'s revenue compounded faster (-8.8% CAGR vs -34.4%).

Mayville Engineering Company, Inc. is a U.S.-headquartered leading manufacturer of metal components, fabricated assemblies, and custom engineered solutions. It serves OEM clients across agriculture, construction, transportation, defense, and power sports markets, offering end-to-end services from prototyping to high-volume production for North America.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

MEC vs MED — Head-to-Head

Bigger by revenue
MEC
MEC
1.8× larger
MEC
$134.3M
$75.1M
MED
Growing faster (revenue YoY)
MEC
MEC
+47.6% gap
MEC
10.7%
-36.9%
MED
More free cash flow
MEC
MEC
$16.8M more FCF
MEC
$10.2M
$-6.6M
MED
Faster 2-yr revenue CAGR
MEC
MEC
Annualised
MEC
-8.8%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MEC
MEC
MED
MED
Revenue
$134.3M
$75.1M
Net Profit
$-4.4M
Gross Margin
6.8%
69.4%
Operating Margin
-4.1%
-10.4%
Net Margin
-3.2%
Revenue YoY
10.7%
-36.9%
Net Profit YoY
-127.3%
EPS (diluted)
$-0.22
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MEC
MEC
MED
MED
Q4 25
$134.3M
$75.1M
Q3 25
$144.3M
$89.4M
Q2 25
$132.3M
$105.6M
Q1 25
$135.6M
$115.7M
Q4 24
$121.3M
$119.0M
Q3 24
$135.4M
$140.2M
Q2 24
$163.6M
$168.6M
Q1 24
$161.3M
$174.7M
Net Profit
MEC
MEC
MED
MED
Q4 25
$-4.4M
Q3 25
$-2.7M
$-2.3M
Q2 25
$-1.1M
$2.5M
Q1 25
$20.0K
$-772.0K
Q4 24
$16.0M
Q3 24
$3.0M
$1.1M
Q2 24
$3.8M
$-8.2M
Q1 24
$3.2M
$8.3M
Gross Margin
MEC
MEC
MED
MED
Q4 25
6.8%
69.4%
Q3 25
11.0%
69.5%
Q2 25
10.3%
72.6%
Q1 25
11.3%
72.8%
Q4 24
8.9%
74.1%
Q3 24
12.6%
75.4%
Q2 24
13.6%
73.2%
Q1 24
13.0%
72.8%
Operating Margin
MEC
MEC
MED
MED
Q4 25
-4.1%
-10.4%
Q3 25
0.0%
-4.6%
Q2 25
0.1%
-1.0%
Q1 25
1.2%
-1.1%
Q4 24
19.0%
0.6%
Q3 24
4.2%
1.5%
Q2 24
5.0%
-4.7%
Q1 24
4.7%
4.5%
Net Margin
MEC
MEC
MED
MED
Q4 25
-3.2%
Q3 25
-1.9%
-2.5%
Q2 25
-0.8%
2.3%
Q1 25
0.0%
-0.7%
Q4 24
13.2%
Q3 24
2.2%
0.8%
Q2 24
2.3%
-4.8%
Q1 24
2.0%
4.8%
EPS (diluted)
MEC
MEC
MED
MED
Q4 25
$-0.22
$-1.64
Q3 25
$-0.13
$-0.21
Q2 25
$-0.05
$0.22
Q1 25
$0.00
$-0.07
Q4 24
$0.76
$0.08
Q3 24
$0.14
$0.10
Q2 24
$0.18
$-0.75
Q1 24
$0.16
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MEC
MEC
MED
MED
Cash + ST InvestmentsLiquidity on hand
$1.5M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$240.7M
$198.9M
Total Assets
$563.6M
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MEC
MEC
MED
MED
Q4 25
$1.5M
$167.3M
Q3 25
$1.2M
$173.5M
Q2 25
$206.0K
$162.7M
Q1 25
$183.0K
$164.6M
Q4 24
$206.0K
$162.3M
Q3 24
$178.0K
$170.0M
Q2 24
$314.0K
$163.5M
Q1 24
$314.0K
$156.4M
Stockholders' Equity
MEC
MEC
MED
MED
Q4 25
$240.7M
$198.9M
Q3 25
$244.8M
$214.7M
Q2 25
$246.8M
$216.0M
Q1 25
$250.0M
$211.0M
Q4 24
$251.8M
$210.1M
Q3 24
$238.4M
$207.3M
Q2 24
$238.1M
$205.3M
Q1 24
$234.0M
$211.0M
Total Assets
MEC
MEC
MED
MED
Q4 25
$563.6M
$248.0M
Q3 25
$585.6M
$268.2M
Q2 25
$433.7M
$269.3M
Q1 25
$447.7M
$280.0M
Q4 24
$445.6M
$284.2M
Q3 24
$466.0M
$291.2M
Q2 24
$488.2M
$293.5M
Q1 24
$499.9M
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MEC
MEC
MED
MED
Operating Cash FlowLast quarter
$13.4M
$-5.3M
Free Cash FlowOCF − Capex
$10.2M
$-6.6M
FCF MarginFCF / Revenue
7.6%
-8.8%
Capex IntensityCapex / Revenue
2.4%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$26.9M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MEC
MEC
MED
MED
Q4 25
$13.4M
$-5.3M
Q3 25
$1.9M
$12.1M
Q2 25
$15.0M
$-3.4M
Q1 25
$8.3M
$3.4M
Q4 24
$38.0M
$-4.9M
Q3 24
$17.9M
$9.1M
Q2 24
$23.3M
$13.1M
Q1 24
$10.6M
$7.3M
Free Cash Flow
MEC
MEC
MED
MED
Q4 25
$10.2M
$-6.6M
Q3 25
$-1.1M
$10.8M
Q2 25
$12.5M
$-4.8M
Q1 25
$5.4M
$1.9M
Q4 24
$35.6M
$-7.2M
Q3 24
$15.1M
$7.7M
Q2 24
$19.2M
$11.1M
Q1 24
$7.8M
$5.4M
FCF Margin
MEC
MEC
MED
MED
Q4 25
7.6%
-8.8%
Q3 25
-0.8%
12.0%
Q2 25
9.5%
-4.5%
Q1 25
4.0%
1.6%
Q4 24
29.4%
-6.1%
Q3 24
11.1%
5.5%
Q2 24
11.7%
6.6%
Q1 24
4.9%
3.1%
Capex Intensity
MEC
MEC
MED
MED
Q4 25
2.4%
1.8%
Q3 25
2.1%
1.5%
Q2 25
1.8%
1.3%
Q1 25
2.2%
1.3%
Q4 24
1.9%
1.9%
Q3 24
2.1%
1.0%
Q2 24
2.5%
1.1%
Q1 24
1.7%
1.1%
Cash Conversion
MEC
MEC
MED
MED
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
416.65×
Q4 24
2.38×
Q3 24
6.03×
8.04×
Q2 24
6.15×
Q1 24
3.28×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MEC
MEC

Fabrication$72.2M54%
Construction And Access$19.2M14%
Tubes$16.2M12%
Other Market$11.9M9%
Agriculture$7.7M6%
Military$6.7M5%
Outdoor Sports$1.7M1%

MED
MED

Segment breakdown not available.

Related Comparisons